 It is commercialized and distributed by Genzyme in the United States, the European Union, and worldwide.The patent for Aldurazyme was filed by BioMarin on November 12, 1999, patent no.US 6426208 B1, "Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof".